Zhou, Q., Long, X., Wang, D., Li, L., Wang, K., Wu, Y., Weng, G., Wu, T., Sun, Y., Li, Q., Yang, Y., Li, G., Song, W., Kalac, M., Lou, J. (2026). A phase 2 study evaluating SSGJ-707 (PF-08634404), a PD-1/VEGF bispecific antibody, + chemotherapy (chemo) in patients (pts) with first-line (1L) advanced/recurrent endometrial cancer (EC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5627